The SENATOR Coordinating Team is pleased to announce that the 1000th patient was randomised to SENATOR. Congratulations to the team in Aberdeen for randomising this milestone patient.
The SENATOR study is a randomized controlled trials (RCTs) towards optimization of pharmacotherapy in old patients. The RCT use software which include also the STOPP/START criteria. The aim of the study is to avoid the prescription of inappropriate medicines and avoidable adverse drug reactions.